Candidate of Biological Sciences, Professor, Head of Laboratory at the Subsidiary of the Holding – Research Institute for Biological Safety Problems

Yerbol Bulatov is the author of 141 scientific works, including 49 articles in national journals, 30 abstracts at international conferences, and 7 publications in peer-reviewed international journals. He also holds 23 national patents, co-authored 30 sets of regulatory and technical documentation (RTD) for diagnostic and preventive products, and authored 2 monographs. His Hirsch index in Web of Science and Scopus is 3.0.

He has been awarded Certificates of Honor from the Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan (2013), the Akim of Zhambyl region (2013), and the Ministry of Education and Science of the Republic of Kazakhstan (2016). For his fruitful work in the fields of education, healthcare, and social protection, as well as for his contribution during the COVID-19 pandemic, he was awarded the “People’s Gratitude” medal (2021). In recognition of his significant contribution to the development of the national higher education system and the training of young qualified specialists, he was also awarded an Honorary Certificate from the Kazakhstan Trade Union of Education and Science Workers.

Y.A. Bulatov is a specialist in cell, virus, and bacteria cultivation, as well as in technologies for the production of prophylactic (preventive) preparations. He has served as a scientific supervisor, principal investigator, and executor in many scientific and technical programs (STP) and projects.

Major Achievements:

• Development of large-scale cultivation protocols for cell cultures and viruses;
• Development of 30 sets of scientific and technical documentation for diagnostic and preventive products;
• Acquisition of 23 patents for strains and methods of vaccine preparation;
• Development of a suspension method for cultivating cell cultures and viruses of peste des petits ruminants (PPR), sheep bluetongue, and rabies virus;
• Implementation of a suspension cultivation method using microcarriers for PPR, bluetongue virus, and rabies virus;
• Development of parameters for cultivating influenza A/H5N1 virus for vaccine production against avian influenza and a recombinant strain against tuberculosis mycobacteria for healthcare;
• On an annual basis, under government procurement, vaccines are produced against sheep pox, contagious ecthyma in sheep and goats, and peste des petits ruminants (PPR).